ArticleAmerican journal of translational research2026
Body mass index is closely correlated with blood lipids, blood pressure, serum uric acid and hepatic steatosis in middle-aged and elderly hypertensive health examinees.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the associations between body mass index (BMI) and blood lipids, blood pressure, serum uric acid, and hepatic steatosis in middle-aged and elderly hypertensive health examinees.
methodsA total of 428 middle-aged and elderly hypertensive participants were divided into underweight/normal (n=146), overweight (n=128) and obese (n=154) groups according to BMI in this retrospective analysis. General clinical data, lipid indicators, blood pressure, serum uric acid, and hepatic steatosis status were collected. Correlation analysis and multivariate regression were used to analyze the relationships between BMI and metabolic indicators and to screen independent risk factors for hepatic steatosis.
resultsCompared with the underweight/normal weight group, overweight and obese participants had adverse metabolic abnormalities and a higher incidence of hepatic steatosis. BMI was positively correlated with triglyceride, low-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure and serum uric acid, and negatively correlated with high-density lipoprotein cholesterol. Age, elevated BMI, systolic blood pressure, serum uric acid and alcoholism were independent risk factors for hepatic steatosis in hypertensive populations.
conclusionIncreased BMI is closely related to dyslipidemia, elevated blood pressure, hyperuricemia and hepatic steatosis in middle-aged and elderly hypertensive individuals. Maintaining a healthy BMI is critical for the prevention of metabolic disorders and hepatic steatosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.